FDA Inspection 1008323 — ImpactLife
The FDA completed an inspection of ImpactLife on January 26, 2017 in Maryville, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 26, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Maryville, IL (United States)